Ingevity Corporation

NGVT • Chemicals - Specialty

$70.54

▲ +0.71 (+1.02%)

Precio actual

ResultadosÚltimo reporte: 30 jun 2026

PERFIL EQUILIBRADONeutralConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Perfil mixto. La empresa no es necesariamente mala, pero la valoración, el crecimiento o el balance todavía no justifican una señal más fuerte.

Capitalización

$2.51B

Crecimiento

2.9%

Flujo de caja

5/5

Tendencia

Stable

Evidencia

Márgenes estables o en mejora · -14.3%Flujo de caja libre positivo · 7.56Flujo de caja libre consistente · 5/5Nivel de deuda alto · 41.84

Datos financieros hasta: 30 jun 2026, 12:00 a.m. UTCÚltima actualización de earnings: 30 jun 2026, 12:00 a.m. UTCÚltima actualización del perfil: 5 ago 2026, 2:27 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$70.54

Change1.02%

Shares Out35.60M

Market Cap$2.51B

Enterprise Value$4.67B

52W Range39.74 - 79.29

Beta1.17

P/E46.50

P/S2.16

P/B53.54

P/FCF16.21

EV/Sales4.03

Price$70.54

Change1.02%

Shares Out35.60M

Market Cap$2.51B

Enterprise Value$4.67B

52W Range39.74 - 79.29

Beta1.17

P/E46.50

P/S2.16

P/B53.54

P/FCF16.21

EV/Sales4.03

EV/EBITDA18.46

EV/FCF30.15

Earnings Yield2.15%

FCF Yield6.17%

Dividend Yield0.00%

Gross Margin39.53%

Oper. Margin22.43%

Profit Margin-14.31%

Debt/Eq41.84

Current Ratio1.15

Quick Ratio0.60

Revenue 5Y2.87%

FCF 5Y10.58%

Target$71.50

Target Upside1.36%

Target Median$73.50

Target Range56.00 - 83.00

Volume387.60K

Avg Volume265.54K

EPS Surprise0.31

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

45/100

Fortaleza financiera

Deuda, caja, estabilidad

34/100

Potencial de crecimiento

Ingresos y expansión

58/100

Atractivo del precio

Barata o cara hoy

56/100

Por qué este puntaje▼

Márgenes estables o en mejora · -14.3%Flujo de caja libre positivo · 7.56Flujo de caja libre consistente · 5/5Nivel de deuda alto · 41.84

Analyst view

Analyst sentiment and price target

NGVT

Analyst sentiment

Based on 13 analyst votes · 2026-09-05

88/100

Bullish

Hold

Bearish

Precio objetivo

2026-07-31

Bajo

$82.00

Promedio

$82.50

Mediana

$82.50

Alto

$83.00

Resumen de la compañía

IPO: 5/3/2016

Industria: Chemicals - Specialty

P/B i: 53.54

Deuda / Patrimonio i: 41.84

Margen operativo: 22.43%

Margen neto: -14.31%

ROE i: -

ROIC: -

Salud financiera

Puntaje7 / 20

Deuda / Patrimonio: 41.84

Ratio corriente: 1.15

Ratio rápido: 0.60

Estado: Weak

Advertencias

High debt level
Weak quick ratio

Transacciones internas

Actividad reciente de ejecutivos e insiders

PLATT PHILLIP JOHN

Transacción: 07/24/2026

VENTA

Cambio

-3,294

Precio

$73.26

Presentación

07/28/2026

Tipo

VENTA

Fisher Ryan C.

Transacción: 07/06/2026

VENTA

Cambio

-168

Precio

$73.86

Presentación

07/08/2026

Tipo

VENTA

Segal Francis David

Transacción: 07/01/2026

COMPRA

Cambio

+328

Precio

$72.58

Presentación

07/02/2026

Tipo

COMPRA

Insider	Tipo	Cambio	Precio	Transacción	Presentación
PLATT PHILLIP JOHN	VENTA	-3,294	$73.26	07/24/2026	07/28/2026
Fisher Ryan C.	VENTA	-168	$73.86	07/06/2026	07/08/2026
Segal Francis David	COMPRA	+328	$72.58	07/01/2026	07/02/2026
WILLIS J KEVIN	COMPRA	+397	$72.58	07/01/2026	07/02/2026
Cotterman Ryan Joseph	OTRO	0	Not reported	06/22/2026	06/24/2026
Cotterman Ryan Joseph	COMPRA	+2,063	Not reported	06/22/2026	06/24/2026
DYER TERRANCE M	VENTA	-200	$68.53	05/28/2026	06/01/2026
PLATT PHILLIP JOHN	COMPRA	+1,262	Not reported	05/01/2026	05/05/2026
Wright Benjamin G.	COMPRA	+1,904	Not reported	04/30/2026	05/01/2026
WILLIS J KEVIN	COMPRA	+1,904	Not reported	04/30/2026	05/01/2026
Segal Francis David	COMPRA	+1,904	Not reported	04/30/2026	05/01/2026
NARWOLD KAREN G	COMPRA	+1,904	Not reported	04/30/2026	05/01/2026
Lynch Frederick J	COMPRA	+1,904	Not reported	04/30/2026	05/01/2026
Hoechner Bruce D.	COMPRA	+1,904	Not reported	04/30/2026	05/01/2026
Gulyas Diane H.	COMPRA	+1,904	Not reported	04/30/2026	05/01/2026
FERNANDEZ-MORENO LUIS M	COMPRA	+1,904	Not reported	04/30/2026	05/01/2026
Li David H	VENTA	-3,574	$70.57	04/07/2026	04/09/2026
WILLIS J KEVIN	COMPRA	+398	$72.28	04/01/2026	04/02/2026
Segal Francis David	COMPRA	+329	$72.28	04/01/2026	04/02/2026
Fisher Ryan C.	VENTA	-308	$71.78	03/25/2026	03/27/2026

Sobre la compañía

Ingevity Corporation

Ingevity Corporation (NGVT) is a global provider specializing in the production and distribution of advanced chemical solutions and activated carbon products. The company's reach extends across North America, the Asia Pacific region, Europe, the Middle East, Africa, and South America. Its business operations are organized into two principal divisions: Performance Materials and Performance Chemicals. The Performance Materials segment focuses on the engineering, manufacturing, and sale of chemically activated carbon products, primarily derived from hardwood. These materials are chiefly utilized in gasoline vapor emission control systems for a wide range of vehicles, including cars, motorcycles, trucks, and boats. Beyond automotive applications, this division also supplies various activated carbon products for purification purposes in areas like food, water, beverages, and industrial chemicals. The Performance Chemicals segment covers pavement technologies, industrial specialty products, and engineered polymers. This division creates products sourced from crude tall oil and lignin, which are extracted during the kraft pulping process, as well as caprolactone monomers and their derivatives, synthesized from cyclohexanone and hydrogen peroxide. The extensive applications for these products include warm mix paving, pavement upkeep and refurbishment, and recycling; additives for oil well services, oil production, and downstream applications; alongside components for adhesives, agricultural dispersants, lubricants, printing inks, industrial intermediates, coatings, resins, elastomers, bioplastics, and medical devices. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

Fuente - Link

Competidores

AAUC ASH CC ELVR FMC IOSP KWR MTX OLN SKE

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

Ingevity CEO Dave Li and CFO Phil Platt to speak at 2026 Jefferies Global Industrials Conference

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity will participate in a fireside chat during the 2026 Jefferies Industrials Conference.

Business Wire

Canada Pension Plan Investment Board Makes New Investment in Ingevity Corporation $NGVT

Canada Pension Plan Investment Board purchased a new stake in Ingevity Corporation (NYSE: NGVT) in the quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 14,900 shares of the company's stock, valued at approximately $1,113,000. Several other institutional investors have also recently made changes to

Defense World

Ingevity (NGVT) Down 0.6% Since Last Earnings Report: Can It Rebound?

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research

Ingevity: Portfolio Simplification Reveals A High-Margin Regulatory Compounder

Ingevity is transforming into a focused, high-margin regulatory compounder, emphasizing Performance Materials and Pavement Technologies after divesting volatile, lower-quality segments. Q2 '26 results highlight margin inflection: adjusted EBITDA rose 14% to $115M, margin expanded to 36.6%, and EPS increased to $1.74, demonstrating strong operating leverage. Hybrid vehicle adoption and infrastructure spending underpin resilient demand for NGVT's emissions-control and pavement solutions, while PFAS filtration offers incremental EBITDA growth optionality.

Seeking Alpha

Why You Should Add Ingevity Stock to Your Portfolio Now

NGVT's raised 2026 outlook, portfolio transformation and new growth platforms support its momentum and higher-return investment focus.

Zacks Investment Research

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-05-06	0.84	1.15	0.31
2026-02-25	0.665	0.58	-0.085
2025-11-05	0.68	1.31	0.63
2025-08-04	1.02	1.39	0.37
2025-05-05	0.74	0.99	0.25
2025-02-18	0.29	0.95	0.66
2024-10-29	0.6	1.1	0.5
2024-07-31	1.05	1.01	-0.04
2024-05-01	0.37	0.52	0.15
2024-02-21	-0.13	0.21	0.34
2023-11-01	1.22	1.21	-0.01
2023-08-02	1.41	1.41	0